Johnson & Johnson’s revenue increased by 4.3% to US$88.821 billion last year, and pharmaceutical sales increased by 5.8%
January 30, 2025
Source: drugdu
32
Recently, Johnson & Johnson released its 2024 Q4 and full-year annual results. It was disclosed that the revenue in Q4 last year was US$22.52 billion, a year-on-year increase of 5.26%. Net profit was US$3.431 billion, a year-on-year decrease of 15.26%.
In 2024, the company achieved revenue of US$88.821 billion, a year-on-year increase of 4.3%, and a year-on-year increase of 7% excluding the impact of exchange rates. The full-year net profit attributable to ordinary shareholders was US$14.066 billion, a year-on-year decrease of 59.99% compared with US$35.153 billion in the same period last year.
Among them, global Johnson & Johnson's innovative pharmaceutical sales were US$57 billion, a year-on-year increase of 5.8%. Global Johnson & Johnson Medical Technology sales were US$31.9 billion, a year-on-year increase of 4.8%.
https://finance.sina.com.cn/
By editor
Copyright©2025 Ddu. All rights reserved.
Read more on
- Baili Tianheng’s revenue is expected to increase by 932% January 30, 2025
- Promoting the “going out” of medicines, my country opens up the “next stop” of medicine centralized procurement for ASEAN January 30, 2025
- Application for registration and marketing authorization of quadrivalent influenza vaccine has been accepted January 30, 2025
- Fosun Pharma’s drug registration application for salbutamol hydrochloride has been accepted January 30, 2025
- encourage and support pharmaceutical operators to strengthen anti-monopoly compliance January 30, 2025
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
